Finding an effective treatment for osteosarcoma, the most common type of bone cancer in children and young adults, has ...
Zacks Investment Research on MSN
KROS stock: What to know about Rinvatercept in DMD
Keros Therapeutics, Inc. KROS is pushing its lead asset, rinvatercept, into neuromuscular disease with Duchenne muscular dystrophy at the front of the line. The company is positioning the program ...
The arterial vasculature is the second most frequently calcified structure in the human body after the skeleton. Calcification of the aorta and aortic valves occurs in most individuals in westernized ...
Researchers uncover how distinct cell populations and fibrotic signals drive permanent scarring after rotator cuff ...
Bone Biologics (NASDAQ:BBLG) is a clinical-stage biotechnology company focused on transforming the multibillion-dollar spine fusion and bone regeneration market through its proprietary orthobiologic ...
The aim of this study was to inhibit adipogenic differentiation by transfecting two growth factors, platelet-derived growth factor (PDGF-BB) and bone morphogenic protein 2 (BMP-2), into modified rat ...
Achondroplasia, also known as short-limb dwarfism, is associated with neurological symptoms and complications due to narrowing of the skeletal structures surrounding the spinal cord. Despite ...
A new analysis of fossil bone growth suggests Tyrannosaurus rex grew far more slowly than scientists once thought, taking nearly 40 years to reach full size. Using advanced statistical methods and ...
‘This is another example of how diseases can develop differently between the sexes,’ professor says, highlighting the value of sex-specific research New research suggests the liver plays a previously ...
PearlMatrix is now the only Class III drug-device spinal bone graft approved for all major lumbar interbody surgical approaches in addition to expanded approved cage materials. Now even more patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results